BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 33346423)

  • 21. [Relationship between long non-coding RNA MALAT1 and prostate cancer].
    Zhang F; Wu CF; Luo YH; Zhou FH
    Zhonghua Nan Ke Xue; 2020 Feb; 26(2):174-179. PubMed ID: 33346423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple function of lncRNA MALAT1 in cancer occurrence and progression.
    Malakoti F; Targhazeh N; Karimzadeh H; Mohammadi E; Asadi M; Asemi Z; Alemi F
    Chem Biol Drug Des; 2023 May; 101(5):1113-1137. PubMed ID: 34918470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MALAT1: A Promising Therapeutic Target for the Treatment of Metastatic Colorectal Cancer.
    Uthman YA; Ibrahim KG; Abubakar B; Bello MB; Malami I; Imam MU; Qusty N; Cruz-Martins N; Batiha GE; Abubakar MB
    Biochem Pharmacol; 2021 Aug; 190():114657. PubMed ID: 34144008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long non-coding RNAs in prostate cancer: An update].
    Wu PG; Zhang YX
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.
    Farzaneh M; Najafi S; Dari MAG; Sheykhi-Sabzehpoush M; Dayer D; Cheraghzadeh M; Azizidoost S
    Clin Transl Oncol; 2023 Jan; 25(1):48-65. PubMed ID: 36042115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.
    Nanni S; Bacci L; Aiello A; Re A; Salis C; Grassi C; Pontecorvi A; Gaetano C; Farsetti A
    Mol Cell Endocrinol; 2020 Jul; 511():110864. PubMed ID: 32413384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MALAT1 -- a paradigm for long noncoding RNA function in cancer.
    Gutschner T; Hämmerle M; Diederichs S
    J Mol Med (Berl); 2013 Jul; 91(7):791-801. PubMed ID: 23529762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer.
    Hao L; Wu W; Xu Y; Chen Y; Meng C; Yun J; Wang X
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MALAT1 in colorectal cancer: Its implication as a diagnostic, prognostic, and predictive biomarker.
    Cervena K; Vodenkova S; Vymetalkova V
    Gene; 2022 Nov; 843():146791. PubMed ID: 35961438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
    Li ZF; Xiao N; Yao YW; Yao ZF
    Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A thorough understanding of the role of lncRNA in prostate cancer pathogenesis; Current knowledge and future research directions.
    Haghighi R; Castillo-Acobo RY; H Amin A; Ehymayed HM; Alhili F; Mirzaei M; Mohammadzadeh Saliani S; Kheradjoo H
    Pathol Res Pract; 2023 Aug; 248():154666. PubMed ID: 37487316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches.
    Amodio N; Raimondi L; Juli G; Stamato MA; Caracciolo D; Tagliaferri P; Tassone P
    J Hematol Oncol; 2018 May; 11(1):63. PubMed ID: 29739426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MALAT1-related signaling pathways in colorectal cancer.
    Xu WW; Jin J; Wu XY; Ren QL; Farzaneh M
    Cancer Cell Int; 2022 Mar; 22(1):126. PubMed ID: 35305641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Insights Into
    Zhou Q; Liu L; Zhou J; Chen Y; Xie D; Yao Y; Cui D
    Front Oncol; 2021; 11():758653. PubMed ID: 34778078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MALAT1: a potential biomarker in cancer.
    Li ZX; Zhu QN; Zhang HB; Hu Y; Wang G; Zhu YS
    Cancer Manag Res; 2018; 10():6757-6768. PubMed ID: 30584369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance.
    Hou J; Zhang G; Wang X; Wang Y; Wang K
    Biomark Res; 2023 Feb; 11(1):23. PubMed ID: 36829256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic studies of MALAT1 in respiratory diseases.
    Wu W; Wang S; Zhang L; Mao B; Wang B; Wang X; Zhao D; Zhao P; Mou Y; Yan P
    Front Mol Biosci; 2022; 9():1031861. PubMed ID: 36419933
    [No Abstract]   [Full Text] [Related]  

  • 39. Long Non-coding RNA MALAT1: A Key Player in Liver Diseases.
    Lu J; Guo J; Liu J; Mao X; Xu K
    Front Med (Lausanne); 2021; 8():734643. PubMed ID: 35145971
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.